Some of our on-going licensing deals include:
Delta Biotechnology Ltd (now Novozymes Biopharma) licensed an improved biopharmaceutical production technology from the School of Biosciences; the first major license from the yeast expression group for application in high yield protein manufacture. A follow up license was secured with US Company BioRexis Inc (subsequently acquired by Pfizer) for use in the production of its unique transferrin tagged proteins.
Harada Industries (Europe) licensed technology from the School of Engineering and Digital Arts for a novel antenna. This technology was subsequently used in Volvo vehicle manufacturing and was incorporated into the top-of-the-range XC90.
If you want to learn more about how IP at the University of Kent can benefit your business, please get in touch by telephone: +44 (0)1227 827376 or by email: email@example.com.
University of Kent staff can view the current IP Policy and frequently asked questions on Sharepoint: